Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
UK Startups and Innovation
13MAY

Innovate UK opens £9.3m rail and agritech competitions

2 min read
20:05UTC

Innovate UK opened two competitions on 11 May: Contracts for Innovation FOAK26 offering £4.3m for rail innovation prototypes, and the Defra Farming Innovation Investor Partnership 2026 offering £5m for agritech SMEs.

TechnologyDeveloping
Key takeaway

Innovate UK opens £9.3m in targeted rail and agritech grants requiring private co-participation under its new portfolio model.

Innovate UK, the UK's innovation agency, opened two competitions on 11 May 2026. 1 The first, Contracts for Innovation FOAK26 (First of a Kind 2026), is funded by the Department for Transport and offers £4.3m for rail innovation prototypes; applications close on 24 June. The second, the Defra Farming Innovation Investor Partnership 2026, offers £5m for agritech small and medium-sized enterprises (SMEs) with private co-participation required; applications close on 17 June.

Both competitions sit within Innovate UK's broader strategic shift, published in a new prospectus in April 2026 , from open-competition grant programmes toward a portfolio management model. Under the new model, Velocity offers ongoing relationship-based account management; Growth Sector Teams actively scout deep-tech companies across six priority sectors; and a High Potential Business Framework evaluates companies on team capability, technical breakthrough, talent pipeline, and market readiness.

The FOAK26 rail competition extends the DARPA-style procurement model into transport infrastructure: the Department for Transport is paying for prototypes to be built and tested inside live rail environments rather than in laboratories, which collapses the typical procurement cycle between concept and operational deployment. The Defra agritech competition's private co-participation requirement means public funding acts as a match rather than a substitute, filtering for companies that have already attracted private investors willing to co-commit.

£9.3m across two competitions is small relative to the investment rounds covered elsewhere in this briefing. The competitions are notable as demand signals rather than as capital flows: they mark two specific technical areas, rail innovation and agritech SMEs, as Innovate UK priority targets under the new portfolio approach, ahead of larger commitments that the Growth Sector Teams may bring forward.

Deep Analysis

In plain English

Innovate UK, the UK government's innovation funding agency, opened two funding competitions on 11 May 2026. The first offers £4.3m for companies that can prototype solutions to persistent rail problems, including safety, punctuality, and anti-social behaviour, and test them in real railway environments rather than laboratories. The second offers £5m to agricultural technology companies that have already attracted private investors, requiring those investors to co-fund alongside the government grant. These competitions are part of a shift in how Innovate UK works: rather than open grants for any promising idea, the agency is now concentrating on specific sectors and requiring companies to demonstrate they are already commercially viable or have the backing to become so. Applications close in June 2026.

First Reported In

Update #4 · State capital lands on UK tech in nine days

UKRI / Innovate UK· 13 May 2026
Read original
Different Perspectives
Australian Department of Defence (AUKUS AI for Acoustics partner)
Australian Department of Defence (AUKUS AI for Acoustics partner)
Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US, and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May brings UK sovereign capital directly into a trilateral programme, which from Canberra's perspective places additional UK government skin-in-the-game on a programme Australia co-funds and co-develops.
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova participated alongside the BBB in Cytospire's oversubscribed £61m Series A on 5 May, demonstrating that the BBB's expanded direct mandate is attracting established European specialist biotech funds rather than replacing them. European VCs see the BBB's cornerstone position as a signal reducing UK biotech execution risk rather than crowding out private capital.
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Singapore's Temasek co-invested alongside the UK's SAIU in Isomorphic's $2.1bn round, treating the same Alphabet-majority company as an acceptable sovereign co-investment target. Temasek's participation normalises the structure: multiple sovereign wealth funds backed the same round, strengthening the precedent that UK-headquartered Alphabet subsidiaries qualify for state investment.
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet co-invested via GV and CapitalG in the same Isomorphic Series B round that received UK sovereign backing, placing US corporate capital and UK public capital in the same syndicate without any governance asymmetry. SAIU's minority stake validates Isomorphic's strategic value without constraining Alphabet's control over IP, geography, or exit decisions.
DSIT / Liz Kendall, Secretary of State for Science
DSIT / Liz Kendall, Secretary of State for Science
DSIT framed the Isomorphic investment as backing a British-founded and headquartered company advancing UK AI capability, and described the nine-day sovereign deployment sprint as evidence the government's industrial strategy is operational. The department has not addressed the ownership question, the absence of eligibility criteria, or the pace-versus-doctrine tension in the BBB mandate.
Beauhurst / UK startup data analysts
Beauhurst / UK startup data analysts
Five sub-£50m rounds closed in nine days with zero VCT-backed angel networks on any cap table, confirming the post-cut investor map is forming fast in the £4m–£40m band. The gap is structural: 36.7% of university spinouts raised below £500,000 in 2025, a tier neither the SAIU nor the BBB direct mandate touches.